Suppr超能文献

[C反应蛋白/白蛋白比值联合血小板计数及格拉斯哥昏迷量表对中暑患者预后的评估价值]

[Evaluation value of C-reactive protein/albumin ratio combined with platelet count and Glasgow coma scale for prognosis of patients with heat stroke].

作者信息

Shi Shanshan, Wu Zhengzhen, Huang Yong, Fu Xianglei

机构信息

Clinical Medicine School of North Sichuan Medical College, Nanchang 637000, Sichuan, China.

Department of Emergency Medicine, Nanchong Center Hospital, Nanchong 637000, Sichuan, China. Corresponding author: Wu Zhengzhen, Email:

出版信息

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025 Feb;37(2):160-164. doi: 10.3760/cma.j.cn121430-20240607-00491.

Abstract

OBJECTIVE

To explore the prognostic value of C-reactive protein (CRP)/albumin (Alb) ratio combined with platelet count (PLT) and Glasgow coma score (GCS) in patients with heat stroke (HS).

METHODS

A retrospective analysis was conducted on the clinical data of HS patients admitted to the department of intensive care unit (ICU) of Nanchong Central Hospital from May 1, 2020 to October 31, 2023. This included general information, admission GCS, laboratory indicators and 28-day prognosis. The differences in the above indicators were compared between two groups of patients with different prognoses. Statistically significant indicators from univariate analysis were included in multivariate Logistic regression analysis to screen for factors influencing 28-day mortality in HS patients. The predictive value of various influencing factors on the 28 days prognosis of HS patients were analyzed by receiver operator characteristic curve (ROC curve).

RESULTS

A total of 73 HS patients were included, of whom 41 survived for 28-day and 32 died. There were no statistically significant differences in gender and age between the two groups of HS patients with different prognoses. The white blood cell count (WBC), neutrophil count (NEU), aspartate aminotransferase (AST), alanine aminotransferase (ALT), CRP, and CRP/Alb ratio in the death group were significantly higher than those of the survival group, and the admission GCS score, platelet count (PLT), total bilirubin (TBil) and Alb were significantly lower than the survival group [WBC (×10/L): 14.80 (11.44, 17.15) vs. 11.96 (9.47, 14.82), NEU (×10/L): 13.05 (8.56, 15.67) vs. 9.50 (6.68, 12.09), AST (U/L): 108.00 (52.70, 291.50) vs. 64.50 (38.25, 110.50), ALT (U/L): 62.00 (19.50, 159.00) vs. 34.50 (20.75, 70.75), CRP (mg/L): 22.49 (3.42, 58.93) vs. 3.68 (1.01, 11.46), CRP/Alb ratio: 0.53 (0.08, 1.77) vs. 0.08 (0.02, 0.44), GCS score: 7.0 (5.0, 8.0) vs. 8.5 (7.0, 11.0), PLT (×10/L): 107.00 (73.50, 126.00) vs. 131.50 (107.50, 176.25), TBil (mmol/L): 15.60 (10.00, 25.30) vs. 21.40 (14.80, 30.05), Alb (g/L): 32.65 (32.53, 49.30) vs. 38.70 (36.20, 40.40), all P < 0.05]. Binary Logistic regression analysis showed that the GCS score [odds ratio (OR) = 0.686, 95% confidence interval (95%CI) was 0.491-0.959, P = 0.028], PLT (OR = 0.973, 95%CI was 0.954-0.992, P = 0.005), NEU (OR = 1.312, 95%CI was 1.072-1.606, P = 0.009) and CRP/Alb ratio (OR = 7.652, 95%CI was 1.632-35.881, P = 0.010) were independent influencing factors for 28-day mortality in HS patients. ROC curve analysis showed that the area under the curve (AUC) of GCS score, PLT, and CRP/Alb ratio for single prediction of 28-day prognosis in HS patients was 0.705, 0.752, and 0.729, and the combination of all three predicted the highest AUC of 28-day prognosis in HS patients (0.917), with a sensitivity and specificity of 86.2% and 81.2%, respectively.

CONCLUSION

CRP/Alb ratio, PLT, and GCS score are independent influencing factors affecting the prognosis of HS patients, and all of them have a certain predictive value for the prognosis of HS patients, in which the combination of the three has a higher predictive value for the prognosis of HS patients.

摘要

目的

探讨C反应蛋白(CRP)/白蛋白(Alb)比值联合血小板计数(PLT)及格拉斯哥昏迷评分(GCS)对热射病(HS)患者预后的评估价值。

方法

回顾性分析2020年5月1日至2023年10月31日期间入住南充市中心医院重症监护病房(ICU)的HS患者的临床资料,包括一般资料、入院时GCS评分、实验室指标及28天预后情况。比较不同预后的两组患者上述指标的差异。将单因素分析中有统计学意义的指标纳入多因素Logistic回归分析,筛选影响HS患者28天死亡率的因素。采用受试者工作特征曲线(ROC曲线)分析各影响因素对HS患者28天预后的预测价值。

结果

共纳入73例HS患者,其中28天存活41例,死亡32例。不同预后的两组HS患者在性别和年龄方面无统计学差异。死亡组患者的白细胞计数(WBC)、中性粒细胞计数(NEU)、天门冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)、CRP及CRP/Alb比值均显著高于存活组,入院时GCS评分、血小板计数(PLT)、总胆红素(TBil)及Alb均显著低于存活组[WBC(×10⁹/L):14.80(11.44,17.15) vs. 11.96(9.47,14.82),NEU(×10⁹/L):13.05(8.56,15.67) vs. 9.50(6.68,12.09),AST(U/L):108.00(52.70,291.50) vs. 64.50(38.25,110.50),ALT(U/L):62.00(19.50,159.00) vs. 34.50(20.75,70.75),CRP(mg/L):22.49(3.42😦 58.93) vs. 3.68(1.01,11.46),CRP/Alb比值:0.53(0.08,1.77) vs. 0.08(0.02,0.44),GCS评分:7.0(5.0,8.0) vs. 8.5(7.0,11.0),PLT(×10⁹/L):107.00(73.50,126.00) vs. 131.50(107.50,176.25),TBil(mmol/L):15.60(10.00,25.30) vs. 21.40(14.80,30.05),Alb(g/L):32.65(32.53,49.30) vs. 38.70(36.20,40.40),均P < 0.05]。二元Logistic回归分析显示,GCS评分[比值比(OR) = 0.686,95%置信区间(95%CI)为0.491 - 0.959,P = 0.028]、PLT(OR = 0.97³,95%CI为0.954 - 0.992,P = 0.005)、NEU(OR = 1.312,95%CI为1.072 - 1.606,P = 0.009)及CRP/Alb比值(OR = 7.65²,95%CI为1.632 - 35.881,P = 0.010)是HS患者28天死亡率的独立影响因素。ROC曲线分析显示GCS评分、PLT及CRP/Alb比值单独预测HS患者28天预后的曲线下面积(AUC)分别为0.😐 5、0.752及0.729,三者联合预测HS患者28天预后的AUC最高(0.917),敏感度和特异度分别为86.2%和81.2%。

结论

CRP/Alb比值、PLT及GCS评分是影响HS患者预后的独立因素,对HS患者预后均有一定的预测价值,三者联合对HS患者预后的预测价值更高。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验